EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes

Lloyd Wei Tat Tang iD, Ethan DaSilva, Kimberly Lapham iD, R Scott Obach

Drug Metabolism and Disposition · 2024

DOI: 10.1124/dmd.124.001693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Lloyd Wei Tat Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut lloydweitat.tang@pfizer.com. Hauptthemen laut MEDLINE: Aldehyde Oxidase, Hepatocytes, Phenotype, Quinazolines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde OxidaseHepatocytesPhenotypeQuinazolinesHumansCrown EthersEnzyme InhibitorsMicrosomes, Liver

Substanzen

Aldehyde OxidaseCrown EthersEnzyme InhibitorsicotinibQuinazolines

Autor:innen und Institutionen

  • Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut lloydweitat.tang@pfizer.com.
  • Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut.

ORCID-Profile: Lloyd Wei Tat Tang, Kimberly Lapham

Zitieren

APA

Tang, L. W. T., DaSilva, E., Lapham, K., & Obach, R. S. (2024). Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001693

Vancouver

Tang LWT, DaSilva E, Lapham K, Obach RS. Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001693

BibTeX
@article{Tang2024,
  author = {Tang, Lloyd Wei Tat and DaSilva, Ethan and Lapham, Kimberly and Obach, R Scott},
  title = {Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  doi = {10.1124/dmd.124.001693}
}
Kostenlos starten →